Body composition plateau and refinement: Fat loss continues but at a slower rate the initial rapid improvement gives way to gradual refinement Lean body mass stabilization at a higher set point Serum protein profile changes consistent with improved metabolic health have been documented in subjects receiving CJC-1295 (PMID: 19386527) Recovery and performance: Training capacity reaches a new baseline recovery that felt enhanced at month 1 now feels normal Injury resilience improves as connective tissue remodeling matures Sleep architecture remains optimized with consistent deep sleep patterns Anti-aging markers: Sustained improvements in skin, hair, and nail quality Improved markers on bloodwork for monitoring guidance, see the CJC-1295 bloodwork biomarkers guide General vitality and recovery capacity that users describe as "feeling younger" Important note on cycling: Community protocols commonly cycle CJC-1295 (8-12 weeks on, 4-8 weeks off), typically for cost and to let IGF-1 normalize
Tirzepatide works on both GIP and GLP-1 receptors, while Semaglutide targets the GLP-1 receptor
Because studies show GH is released predominantly at night and in pulses in humans, and CJC-1295 preserves this natural pulsatility
Book a consultation with our expert practitioners at Boon Aesthetics today, and discover how we can tailor this revolutionary treatment to meet your unique body goals take the first step towards a new, more confident you!
Search for your preferred semaglutide option (Ozempic, Wegovy, or Rybelsus)
01751-7/asset/6309d074-38cb-40bc-984b-962ca1dbd6df/main.assets/gr2b_lrg.jpg)
